A phase 1 study of the proteasome inhibitor bortezomib in pediatric patients with refractory leukemia: a Children's Oncology Group study. (Q53735140)

From Wikidata

Jump to navigation Jump to search

scientific article

Language	Label	Description	Also known as
English	A phase 1 study of the proteasome inhibitor bortezomib in pediatric patients with refractory leukemia: a Children's Oncology Group study.	scientific article

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

18 May 2018

http://europepmc.org/abstract/MED/17332297

A phase 1 study of the proteasome inhibitor bortezomib in pediatric patients with refractory leukemia: a Children's Oncology Group study. (English)

1 reference

Europe PubMed Central

PubMed publication ID

18 May 2018

http://europepmc.org/abstract/MED/17332297

0 references

1 reference

based on heuristic

inferred from title

11

object named as

Susan M Blaney

1 reference

Europe PubMed Central

PubMed publication ID

18 May 2018

author name string

Terzah M Horton

1

1 reference

Europe PubMed Central

PubMed publication ID

18 May 2018

http://europepmc.org/abstract/MED/17332297

Debananda Pati

2

1 reference

Europe PubMed Central

PubMed publication ID

18 May 2018

http://europepmc.org/abstract/MED/17332297

Sharon E Plon

3

1 reference

Europe PubMed Central

PubMed publication ID

18 May 2018

http://europepmc.org/abstract/MED/17332297

Patrick A Thompson

4

1 reference

Europe PubMed Central

PubMed publication ID

18 May 2018

http://europepmc.org/abstract/MED/17332297

Lisa R Bomgaars

5

1 reference

Europe PubMed Central

PubMed publication ID

18 May 2018

http://europepmc.org/abstract/MED/17332297

Peter C Adamson

6

1 reference

Europe PubMed Central

PubMed publication ID

18 May 2018

http://europepmc.org/abstract/MED/17332297

Ashish M Ingle

7

1 reference

Europe PubMed Central

PubMed publication ID

18 May 2018

http://europepmc.org/abstract/MED/17332297

John Wright

8

1 reference

Europe PubMed Central

PubMed publication ID

18 May 2018

http://europepmc.org/abstract/MED/17332297

Adam H Brockman

9

1 reference

Europe PubMed Central

PubMed publication ID

18 May 2018

http://europepmc.org/abstract/MED/17332297

Martin Paton

10

1 reference

Europe PubMed Central

PubMed publication ID

18 May 2018

http://europepmc.org/abstract/MED/17332297

language of work or name

0 references

publication date

1 March 2007

1 reference

Europe PubMed Central

PubMed publication ID

18 May 2018

http://europepmc.org/abstract/MED/17332297

Clinical Cancer Research

1 reference

Europe PubMed Central

PubMed publication ID

18 May 2018

http://europepmc.org/abstract/MED/17332297

13

1 reference

Europe PubMed Central

PubMed publication ID

18 May 2018

http://europepmc.org/abstract/MED/17332297

5

1 reference

Europe PubMed Central

PubMed publication ID

18 May 2018

http://europepmc.org/abstract/MED/17332297

1516-1522

1 reference

Europe PubMed Central

PubMed publication ID

18 May 2018

http://europepmc.org/abstract/MED/17332297

Identifiers

10.1158/1078-0432.CCR-06-2173

1 reference

Europe PubMed Central

PubMed publication ID

18 May 2018

http://europepmc.org/abstract/MED/17332297

release_tk2yz5n4cnafjbmwtfyuxddh4y

1 reference

https://api.fatcat.wiki/v0/release/tk2yz5n4cnafjbmwtfyuxddh4y

24 November 2022

based on heuristic

mapped directly with Wikidata item

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

18 May 2018

http://europepmc.org/abstract/MED/17332297

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q53735140&oldid=1843955156"